|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Secondary (AA) Amyloidosis | |||||
| Rheumatoid Arthritis | |||||
| Nephrotic Syndrome | |||||
| Familial Mediterranean Syndrome | |||||
| Kidney Diseases | |||||
| Gastrointestinal Diseases | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Amyloidosis | |||||
| Arthritis | |||||
| Arthritis, Rheumatoid | |||||
| Neoplasm Metastasis | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Connective Tissue Diseases | |||||
| Digestive System Diseases | |||||
| Disease | |||||
| Immune System Diseases | |||||
| Joint Diseases | |||||
| Metabolic Diseases | |||||
| Musculoskeletal Diseases | |||||
| Neoplasms | |||||
| Neoplastic Processes | |||||
| Nephrosis | |||||
| Pathologic Processes | |||||
| Rheumatic Diseases | |||||
| Urologic Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| Bellus Health Inc | |||||
| FDA Office of Orphan Products Development | |||||